RAS-targeted therapies: is the undruggable drugged?
AR Moore, SC Rosenberg, F McCormick… - Nature reviews Drug …, 2020 - nature.com
Abstract RAS (KRAS, NRAS and HRAS) is the most frequently mutated gene family in
cancers, and, consequently, investigators have sought an effective RAS inhibitor for more …
cancers, and, consequently, investigators have sought an effective RAS inhibitor for more …
RAS-targeted therapies: is the undruggable drugged?
AR Moore, SC Rosenberg, F McCormick… - Nature Reviews Drug …, 2020 - escholarship.org
RAS (KRAS, NRAS and HRAS) is the most frequently mutated gene family in cancers, and,
consequently, investigators have sought an effective RAS inhibitor for more than three …
consequently, investigators have sought an effective RAS inhibitor for more than three …
RAS-targeted therapies: is the undruggable drugged?
AR Moore, SC Rosenberg, F McCormick… - Nature Reviews Drug …, 2020 - nature.com
Abstract RAS (KRAS, NRAS and HRAS) is the most frequently mutated gene family in
cancers, and, consequently, investigators have sought an effective RAS inhibitor for more …
cancers, and, consequently, investigators have sought an effective RAS inhibitor for more …
RAS-targeted therapies: is the undruggable drugged?
AR Moore, SC Rosenberg, F McCormick… - Nature reviews. Drug …, 2020 - europepmc.org
Abstract RAS (KRAS, NRAS and HRAS) is the most frequently mutated gene family in
cancers, and, consequently, investigators have sought an effective RAS inhibitor for more …
cancers, and, consequently, investigators have sought an effective RAS inhibitor for more …
RAS-targeted therapies: is the undruggable drugged?
AR Moore, SC Rosenberg, F McCormick… - Nature Reviews Drug …, 2020 - go.gale.com
RAS (KRAS, NRAS and HRAS) is the most frequently mutated gene family in cancers, and,
consequently, investigators have sought an effective RAS inhibitor for more than three …
consequently, investigators have sought an effective RAS inhibitor for more than three …
[引用][C] RAS-targeted therapies: is the undruggable drugged?
AR Moore, SC Rosenberg, F McCormick… - Nature Reviews Drug …, 2020 - cir.nii.ac.jp
RAS-targeted therapies: is the undruggable drugged? | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
RAS-targeted therapies: is the undruggable drugged?
AR Moore, SC Rosenberg… - Nature reviews …, 2020 - pubmed.ncbi.nlm.nih.gov
RAS (KRAS, NRAS and HRAS) is the most frequently mutated gene family in cancers, and,
consequently, investigators have sought an effective RAS inhibitor for more than three …
consequently, investigators have sought an effective RAS inhibitor for more than three …
[HTML][HTML] RAS-targeted therapies: is the undruggable drugged?
AR Moore, SC Rosenberg, F McCormick… - Nature reviews. Drug …, 2020 - ncbi.nlm.nih.gov
Abstract RAS (KRAS, NRAS and HRAS) is the most frequently mutated gene family in
cancers, and, consequently, investigators have sought an effective RAS inhibitor for more …
cancers, and, consequently, investigators have sought an effective RAS inhibitor for more …
[引用][C] RAS-targeted therapies
AR Moore, SC Rosenberg… - Nature reviews. Drug … - pubmed.ncbi.nlm.nih.gov
RAS-targeted therapies: is the undruggable drugged?
AR Moore, SC Rosenberg, F McCormick… - Nature reviews. Drug …, 2020 - europepmc.org
Abstract RAS (KRAS, NRAS and HRAS) is the most frequently mutated gene family in
cancers, and, consequently, investigators have sought an effective RAS inhibitor for more …
cancers, and, consequently, investigators have sought an effective RAS inhibitor for more …